J. Corre, N. Munshi, and H. Avet-loiseau, Genetics of multiple myeloma: another heterogeneity level?, Blood, vol.125, issue.12, pp.1870-1876, 2015.
DOI : 10.1182/blood-2014-10-567370

R. Fonseca, L. Bergsagel, P. Drach, J. Shaughnessy, J. Gutierrez et al., International Myeloma Working Group molecular classification of multiple myeloma: spotlight review, Leukemia, vol.91, issue.12, pp.2210-2221, 2009.
DOI : 10.1016/j.beha.2007.08.004

G. Morgan, B. Walker, and F. Davies, The genetic architecture of multiple myeloma, Nature Reviews Cancer, vol.214, issue.5, pp.335-348, 2012.
DOI : 10.1038/nrc3257

N. Munshi, K. Anderson, P. Bergsagel, J. Shaughnessy, A. Palumbo et al., Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2, Blood, vol.117, issue.18, pp.4696-4700, 2011.
DOI : 10.1182/blood-2010-10-300970

A. and R. Sv, Interpretation of cytogenetic results in multiple myeloma for clinical practice, Blood Cancer J, vol.5, p.365, 2015.

T. Vu, W. Gonsalves, S. Kumar, A. Dispenzieri, M. Lacy et al., Characteristics of exceptional responders to lenalidomide-based therapy in multiple myeloma, Blood Cancer Journal, vol.122, issue.10, p.363, 2015.
DOI : 10.1038/bcj.2013.34

C. Leow, C. Gerondakis, S. Spencer, and A. , MEK inhibitors as a chemotherapeutic intervention in multiple myeloma, Blood Cancer Journal, vol.9, issue.3, p.105, 2013.
DOI : 10.1182/blood-2010-04-278788

P. Kapoor and S. Rajkumar, Update on risk stratification and treatment of newly diagnosed multiple myeloma, International Journal of Hematology, vol.28, issue.19, pp.310-320, 2011.
DOI : 10.1007/s12185-011-0947-z

J. Mikhael, D. Dingli, V. Roy, C. Reeder, F. Buadi et al., Management of Newly Diagnosed Symptomatic Multiple Myeloma: Updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines 2013, Mayo Clinic Proceedings, vol.88, issue.4, pp.360-376, 2013.
DOI : 10.1016/j.mayocp.2013.01.019

M. Chapman, M. Lawrence, J. Keats, K. Cibulskis, C. Sougnez et al., Initial genome sequencing and analysis of multiple myeloma, Nature, vol.47, issue.7339, pp.467-472, 2011.
DOI : 10.1038/nature09837

B. Walker, C. Wardell, L. Melchor, S. Hulkki, N. Potter et al., Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myeloma, Blood, vol.120, issue.5, pp.1077-1086, 2012.
DOI : 10.1182/blood-2012-03-412981

N. Bolli, H. Avet-loiseau, D. Wedge, V. Loo, P. Alexandrov et al., Heterogeneity of genomic evolution and mutational profiles in multiple myeloma, Nature Communications, vol.173, p.2997, 2014.
DOI : 10.1038/ncomms3997

J. Lohr, P. Stojanov, S. Carter, P. Cruz-gordillo, M. Lawrence et al., Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy, Cancer Cell, vol.25, issue.1, pp.91-101, 2014.
DOI : 10.1016/j.ccr.2013.12.015

A. Palumbo, H. Avet-loiseau, S. Oliva, H. Lokhorst, H. Goldschmidt et al., Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group, Journal of Clinical Oncology, vol.33, issue.26, pp.2863-2869, 2015.
DOI : 10.1200/JCO.2015.61.2267

N. Bolli, N. Manes, T. Mckerrell, C. J. Park, N. Gundem et al., Characterization of gene mutations and copy number changes in acute myeloid leukemia using a rapid target enrichment protocol, Haematologica, vol.100, issue.2, pp.214-222, 2015.
DOI : 10.3324/haematol.2014.113381

N. Conte, I. Varela, C. Grove, N. Manes, K. Yusa et al., Detailed molecular characterisation of acute myeloid leukaemia with a normal karyotype using targeted DNA capture, Leukemia, vol.93, issue.9, pp.1820-1825, 2013.
DOI : 10.1056/NEJMoa0810069

E. Papaemmanuil, M. Gerstung, L. Malcovati, S. Tauro, G. Gundem et al., Clinical and biological implications of driver mutations in myelodysplastic syndromes, Blood, vol.122, issue.22, pp.3616-3627, 2013.
DOI : 10.1182/blood-2013-08-518886

T. Haferlach, Y. Nagata, V. Grossmann, Y. Okuno, U. Bacher et al., Landscape of genetic lesions in 944 patients with myelodysplastic syndromes, Leukemia, vol.82, issue.2, pp.241-247, 2014.
DOI : 10.1038/leu.2013.336

E. Donnell, A. Mahindra, A. Yee, V. Nardi, N. Birrer et al., Clinical Grade ???SNaPshot??? Genetic Mutation Profiling in Multiple Myeloma, EBioMedicine, vol.2, issue.1, pp.71-73, 2015.
DOI : 10.1016/j.ebiom.2014.11.008

K. Kortüm, C. Langer, J. Monge, L. Bruins, J. Egan et al., P) in -17p high risk disease, British Journal of Haematology, vol.120, issue.4, pp.507-510, 2015.
DOI : 10.1111/bjh.13171

B. Walker, C. Wardell, D. Johnson, M. Kaiser, D. Begum et al., Characterization of IGH locus breakpoints in multiple myeloma indicates a subset of translocations appear to occur in pregerminal center B cells, Blood, vol.121, issue.17, pp.3413-3419, 2013.
DOI : 10.1182/blood-2012-12-471888

. Genomes-project-consortium, A. Auton, L. Brooks, R. Durbin, H. Kang et al., An integrated map of genetic variation from 1,092 human genomes, Nature, vol.491, pp.56-65, 2012.

H. Li and R. Durbin, Fast and accurate long-read alignment with Burrows-Wheeler transform, Bioinformatics, vol.26, issue.5, pp.589-595, 2010.
DOI : 10.1093/bioinformatics/btp698

A. Quinlan and I. Hall, BEDTools: a flexible suite of utilities for comparing genomic features, Bioinformatics, vol.26, issue.6, pp.841-842, 2010.
DOI : 10.1093/bioinformatics/btq033

S. Forbes, D. Beare, P. Gunasekaran, K. Leung, N. Bindal et al., COSMIC: exploring the world's knowledge of somatic mutations in human cancer, Nucleic Acids Research, vol.43, issue.D1, pp.805-811, 2015.
DOI : 10.1093/nar/gku1075

S. Nik-zainal, L. Alexandrov, D. Wedge, V. Loo, P. Greenman et al., Mutational Processes Molding the Genomes of 21 Breast Cancers, Cell, vol.149, issue.5, pp.979-993, 2012.
DOI : 10.1016/j.cell.2012.04.024

C. Rubio-perez, D. Tamborero, M. Schroeder, A. Antolín, J. Deu-pons et al., In Silico Prescription of Anticancer Drugs to Cohorts of 28 Tumor Types Reveals Targeting Opportunities, Cancer Cell, vol.27, issue.3, pp.382-396, 2015.
DOI : 10.1016/j.ccell.2015.02.007

S. Leal-ortiz, C. Waites, R. Terry-lorenzo, P. Zamorano, E. Gundelfinger et al., Piccolo modulation of Synapsin1a dynamics regulates synaptic vesicle exocytosis, The Journal of Cell Biology, vol.65, issue.5, pp.831-846, 2008.
DOI : 10.1038/nrn1370

J. Lohr, P. Stojanov, M. Lawrence, D. Auclair, B. Chapuy et al., Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing, Proceedings of the National Academy of Sciences, vol.109, issue.10, pp.3879-3884, 2012.
DOI : 10.1073/pnas.1121343109

A. Mcelhinny, S. Kazmierski, S. Labeit, and C. Gregorio, Nebulin The Nebulous, Multifunctional Giant of Striated Muscle, Trends in Cardiovascular Medicine, vol.13, issue.5, pp.195-201, 2003.
DOI : 10.1016/S1050-1738(03)00076-8

M. Lawrence, P. Stojanov, P. Polak, G. Kryukov, K. Cibulskis et al., Mutational heterogeneity in cancer and the search for new cancer-associated genes, Nature, vol.31, issue.7457, pp.214-218, 2013.
DOI : 10.1038/nature12213

H. Avet-loiseau, C. Li, F. Magrangeas, W. Gouraud, C. Charbonnel et al., Prognostic Significance of Copy-Number Alterations in Multiple Myeloma, Journal of Clinical Oncology, vol.27, issue.27
DOI : 10.1200/JCO.2008.20.6136

M. Nobuyoshi, M. Kawano, H. Tanaka, H. Ishikawa, O. Tanabe et al., Increased expression of the c-myc gene may be related to the aggressive transformation of human myeloma cells, British Journal of Haematology, vol.230, issue.4, pp.523-528, 1991.
DOI : 10.1111/j.1365-2141.1991.tb08620.x

S. Porter, L. Baker, D. Mittelman, and M. Porteus, Lentiviral and targeted cellular barcoding reveals ongoing clonal dynamics of cell lines in vitro and in vivo, Genome Biology, vol.15, issue.5
DOI : 10.1089/hum.2010.068

B. Walker, E. Boyle, C. Wardell, A. Murison, D. Begum et al., Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma, Journal of Clinical Oncology, vol.33, issue.33, pp.3911-3920, 2015.
DOI : 10.1200/JCO.2014.59.1503

J. Martinez-lopez, J. Lahuerta, F. Pepin, M. González, S. Barrio et al., Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma, Blood, vol.123, issue.20, pp.3073-3079, 2014.
DOI : 10.1182/blood-2014-01-550020

S. Rajkumar, M. Dimopoulos, A. Palumbo, J. Bladé, G. Merlini et al., International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma, The Lancet Oncology, vol.15, issue.12, pp.538-548, 2014.
DOI : 10.1016/S1470-2045(14)70442-5

N. Rashid, A. Sperling, N. Bolli, D. Wedge, V. Loo et al., Differential and limited expression of mutant alleles in multiple myeloma, Blood, vol.124, issue.20, pp.3110-3117, 2014.
DOI : 10.1182/blood-2014-04-569327